Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
about
The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stabilityFBXW7-mediated degradation of CCDC6 is impaired by ATM during DNA damage response in lung cancer cellsPI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activityParkin-dependent degradation of the F-box protein Fbw7β promotes neuronal survival in response to oxidative stress by stabilizing Mcl-1Mitochondria, cholesterol and cancer cell metabolismTumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapyTargeting the Mitotic Catastrophe Signaling Pathway in CancerRegulation of Bim in Health and DiseaseTargeting the ubiquitin pathway for cancer treatmentThe BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer TherapeuticsGenetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligasesRational Design of Proteolytically Stable, Cell-Permeable Peptide-Based Selective Mcl-1 InhibitorsSelective Aurora Kinase Inhibitors Identified Using a Taxol-Induced Checkpoint Sensitivity ScreenDiscovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based DesignA1/Bfl-1 in leukocyte development and cell deathDiscovery of tricyclic indoles that potently inhibit Mcl-1 using fragment-based methods and structure-based designDiscovery of 2-Indole-acylsulfonamide Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based MethodsPrediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients.Mitochondrial apoptosis and BH3 mimeticsDysregulation of ubiquitin ligases in cancerExploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy CombinationThr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancerWogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549Multi-agent chemotherapy overcomes glucocorticoid resistance conferred by a BIM deletion polymorphism in pediatric acute lymphoblastic leukemiaA Maltose-Binding Protein Fusion Construct Yields a Robust Crystallography Platform for MCL1Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment.Spindle poisons and cell fate: a tale of two pathways.DEPDC1/LET-99 participates in an evolutionarily conserved pathway for anti-tubulin drug-induced apoptosis.Prolonged mitotic arrest triggers partial activation of apoptosis, resulting in DNA damage and p53 inductionModulating cell-to-cell variability and sensitivity to death ligands by co-drugging.Tumour cell survival mechanisms in lethal metastatic prostate cancer differ between bone and soft tissue metastases.The NOXA-MCL1-BIM axis defines lifespan on extended mitotic arrestUSP9X regulates centrosome duplication and promotes breast carcinogenesis.A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.FBXW7 expression is associated with prognosis and chemotherapeutic outcome in Chinese patients with gastric adenocarcinomaAberrant regulation of FBW7 in cancer.Pretubulysin: a new option for the treatment of metastatic cancer.An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cellsRational combination of dual PI3K/mTOR blockade and Bcl-2/-xL inhibition in AML.
P2860
Q24296476-D364151E-3B0B-43CD-917B-FA57541B2168Q24302090-A78C201B-E73E-4532-B68A-E01E79C91025Q24304880-E5719B82-C1A6-4DAE-886E-64B5646E430CQ24308897-C1FB026D-7ABC-4F4E-9EB7-A199C00F2D87Q26741708-C06AF26B-139C-46DC-80B7-D4D14FFA577CQ26768521-2DD31A61-BC5B-4B06-9079-08C4622FBDD5Q26778544-D6F130A8-9716-409C-ACED-84ABBE603E17Q26781203-F88C1725-3BA1-47D1-AB8F-6C46336F39ECQ26866185-192B178E-BD51-4F57-9474-50F037D69EE4Q27010154-439CDD72-BCC0-43E5-9FB9-8A0AA21BB1BCQ27027897-C4AE7CA7-D660-4968-95FC-5DE9B70F16ECQ27671680-367B5C04-D50F-45A0-8DC9-2A373A37860AQ27674986-C707A148-1859-4D60-BFD6-E5668B1E78D6Q27675512-4181D9AA-23F5-4C51-BE54-63EB4070A7D8Q27691571-B28226FF-3020-48F5-AD8D-50A8FB76BE37Q27700088-6EF2C8F8-86CA-4F8C-880B-F0B2658FF461Q27704027-8B798FE0-C06B-4B57-BFDF-43E34DA4EA96Q27853234-F78A6ADD-54E8-465D-A1AC-1A94D065E7D3Q28069552-A655D852-6A86-4265-B653-BA7774E45240Q28086796-85749546-5EDA-4A76-B5CB-1D2660417FA9Q28118450-87B9685F-A65E-487D-B4B7-CC88A7700ED6Q28484291-9AA9A54B-C31F-4D85-9E8C-D5EA7119F90CQ28535037-56241720-7433-4D18-967F-416727512ACBQ28541556-D92E73A2-9651-4326-9D53-AC08164559D9Q28546678-D16A4815-5D68-47C0-A998-33A3C3A835AFQ30418482-F1221984-F700-4DE6-8973-7928F899788CQ30431071-4CF31AAA-19A3-4409-BD27-F4080D63D7E5Q30458737-D3D6FF7D-5AD7-48C6-B789-D2AE5F2AB44DQ30505355-E376F552-12A6-434B-A4E0-697D5668F997Q30544925-EABC17E7-58E1-49D3-9EFD-01BCF7883BF5Q30572057-B80F1999-7DFE-4D38-979D-199DB257E043Q30648719-37CB508B-8CDD-4FE7-B417-FB3186E61993Q30844123-B2567D5D-0A9C-43A2-9223-3E2612FC55D3Q31016573-9E8A21E0-0748-4345-B10B-D52F53887CD5Q33560133-4C4252B4-4839-4DAB-95E1-77284238B1E9Q33630452-4DCFE5B4-6CDB-44E0-ABD1-C282222A4A21Q33688508-66987827-A815-444E-A47C-00B1BA311354Q33695171-A4704C5E-F980-4EAB-86ED-713DB1A7C50AQ33709439-302B4BD4-3347-497A-8F1B-B7AFF0F0940BQ33840360-C6756264-739C-419A-8D52-F50A7FBD9583
P2860
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@en
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@nl
type
label
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@en
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@nl
prefLabel
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@en
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@nl
P2093
P50
P356
P1433
P1476
Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
@en
P2093
Adam R Johnson
Cynthia Lam
David C S Huang
Erin C Dueber
Heather Maecker
Ingrid E Wertz
James A Ernst
Jennie R Lill
Josh S Kaminker
Kanan Pujara
P2888
P304
P356
10.1038/NATURE09779
P407
P577
2011-03-01T00:00:00Z
P5875
P6179
1050839842